Local inflammation, endothelial dysfunction and fibrinolysis in coronary heart disease

被引:8
作者
Lowe, GDO [1 ]
机构
[1] Univ Glasgow, Royal Infirm, Univ Dept Med, Glasgow G31 2ER, Lanark, Scotland
关键词
atherothrombosis; coronary heart disease; endothelial function; inflammation; tissue plasminogen activator (t-PA); tumour necrosis factor-alpha (TNF-alpha);
D O I
10.1042/CS20060002
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prospective epidemiological studies have shown associations of circulating inflammatory markers with risk of CHD (coronary heart disease); however, these associations are modest after adjustment for confounding by established risk factors, and do not add significantly to the predictive value of current clinical risk scores. In contrast, experimental human studies of local arterial inflammation, such as the brachial artery infusion of TNF-alpha (tumour necrosis factor-alpha.) model reported in this issue of Clinical Science by Robinson and co-workers, are of value in elucidating the pathophysiology of atherothrombosis.
引用
收藏
页码:327 / 328
页数:2
相关论文
共 10 条
[1]  
DEBONO D, 1994, BRIT HEART J, V71, P504
[2]   FLUID-FLOW STIMULATES TISSUE PLASMINOGEN-ACTIVATOR SECRETION BY CULTURED HUMAN-ENDOTHELIAL CELLS [J].
DIAMOND, SL ;
ESKIN, SG ;
MCINTIRE, LV .
SCIENCE, 1989, 243 (4897) :1483-1485
[3]   When is a new prediction marker useful?: A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk [J].
Greenland, P ;
O'Malley, PG .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2454-2456
[4]   Acute systemic inflammation impairs endothelium-dependent dilatation in humans [J].
Hingorani, AD ;
Cross, J ;
Kharbanda, RK ;
Mullen, MJ ;
Bhagat, K ;
Taylor, M ;
Donald, AE ;
Palacios, M ;
Griffin, GE ;
Deanfield, JE ;
MacAllister, RJ ;
Vallance, P .
CIRCULATION, 2000, 102 (09) :994-999
[5]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143
[6]   Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease [J].
Lowe, GDO .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) :1618-1627
[7]   Tissue plasminogen activator antigen and coronary heart disease [J].
Lowe, GDO ;
Danesh, J ;
Lewington, S ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Rumley, A ;
Whincup, PH .
EUROPEAN HEART JOURNAL, 2004, 25 (03) :252-259
[8]   Vascular and fibrinolytic effects of intra-arterial tumor necrosis factor-α in patients with coronary heart disease [J].
Robinson, SD ;
Dawson, P ;
Ludlam, CA ;
Boon, NA ;
Newby, DE .
CLINICAL SCIENCE, 2006, 110 (03) :353-360
[9]   Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries [J].
Steins, MB ;
Padró, T ;
Li, CX ;
Mesters, RM ;
Ostermann, H ;
Hammel, D ;
Scheld, HH ;
Berdel, WE ;
Kienast, J .
ATHEROSCLEROSIS, 1999, 145 (01) :173-180
[10]   C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study [J].
Wilson, PWF ;
Nam, BH ;
Pencina, M ;
D'Agostino, RB ;
Benjamin, EJ ;
O'Donnell, CJ .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (21) :2473-2478